Back to search

Poland· PL-100071155

Vitaminum B2 Teva

A riboflavin (vit b2) product containing riboflavinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC A11HA04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVitaminum B2 TevaATCA11HA04REGISTER NO.PL-100071155PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Riboflavin (vit b2) is registered in 5 of 19 countries.

Countries holding a registration under ATC A11HA04 (riboflavin (vit b2)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Riboflavin (vit b2) · ATC A11HA04

5 / 19 countries

  • Finlandprice
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Riboflavinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
A11HA04
ATC class
Riboflavin (vit B2)
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990203611

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Riboflavin (vit b2) in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All riboflavin (vit b2) products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Vitamin B2 Axicur®

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2599ec80-3800-4a3b-8b2c-ade503f2dd33
GET /v1/drugs/2599ec80-3800-4a3b-8b2c-ade503f2dd33?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "3 mg",
  "packaging": "Rp ¦ Skasowane ¦ 10708\n20 draż. \n05909990203611 ¦ OTC ¦ 10709\n50 tabl.",
  "substance": "Riboflavinum (Vitaminum B2) 3 mg",
  "common_name": "Riboflavinum",
  "pl_product_id": "100071155",
  "pozwolenie_nr": "02036",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about riboflavin (vit b2).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.